Huahao Zhongtian Medical-B (02563): Four clinical research results of Optidelong selected for the American Society of Clinical Oncology (ASCO) Annual Meeting 2026.

Wisdom Financial APP News, Huahao Zhongtian Medicine-B (02563) announced that the latest clinical research data of the company's core products Utoride Long Injection ("UTD1") and Utoride Long Capsule ("UTD2") have been selected for presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting ("2026 ASCO Annual Meeting").